Psy Therapeutics
About:
Psy Therapeutics discovers and develops novel medicines to improve the lives of people affected by central nervous system disorders.
Website: https://www.psythx.com/
Top Investors: WPSS.bio, Ayuh Ventures
Description:
Psy Therapeutics is discovering and developing novel medicines to improve the lives of people affected by central nervous system (CNS) disorders. The company focuses on anxiety, depression, and dementia to improve neuropsychiatric care.
Total Funding Amount:
$3.97M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Boston, Massachusetts, United States
Founded Date:
2012-01-01
Founders:
Jerrold Rosenbaum, Maurizio Fava, Roy Perlis
Number of Employees:
11-50
Last Funding Date:
2022-04-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai